You are here

Relovair

GlaxoSmithKline's Q1 Call Has Muted Mention Of Relovair

Seeking Alpha

Sun, 04/29/12 - 12:32 pm

Breathe Easy: Relovair Program Complete, Data Solid

Motley Fool

Thu, 03/29/12 - 12:02 pm

GSK lung drug has mixed results but filing on track

Reuters

Fri, 03/23/12 - 12:22 pm

Theravance: A $1.5 Billion Company With An $8 Billion Product

Seeking Alpha

Wed, 02/22/12 - 05:47 pm

For Theravance Investors, GlaxoSmithKline Won't Be The Answer

Seeking Alpha

Thu, 01/12/12 - 08:30 am

Theravance shares make modest rebound

Marketwatch

Wed, 01/11/12 - 12:38 pm

Theravance Shares Slide on Lung Drug Deaths

TheStreet.com

Mon, 01/9/12 - 09:51 am

GSK Sets Stage for Big Late-Stage Drug Events, Potential Blockbusters

Motley Fool

Wed, 11/2/11 - 11:14 am

GlaxoSmithKline Investors Nervous After Relovair Reports Mixed Data

Seeking Alpha

Mon, 06/6/11 - 09:19 am

New GSK lung drug hits most targets in two studies

Yahoo/Reuters

Fri, 06/3/11 - 09:18 am

Theravance Attractive After Novartis' Fumble

Minyanville

Wed, 03/9/11 - 02:25 pm

Theravance Poised to Jump

Minyanville

Sat, 02/5/11 - 11:01 am

Glaxo, Theravance report Relovair safety data

Yahoo/AP

Wed, 09/22/10 - 09:57 am